Arxis, Inc. insider trading
ARXS$50.03+2.51 (+5.28% today)
“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”
Insider Trading vs Stock Price
Insider Trading vs Stock Price data
Showing the 1Y range: Apr 16, 2026 to Oct 2, 2026. Price (+29.1%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.
| Date | Category | Person | Role | Action | Amount | Change in holding |
|---|
Open market purchase
Open market sellNet dollar flow · Buy / Sell balance
PremiumQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Unlock quarterly net flowKey players
- KSKevin Scott Perhamus4.6527%
- RBRoss Bradley Sealfon1.436%
- JAJason Aaron Roth0.5594%
- ASAzad Sid Badakhsh0.5259%
- RARyan Anthony Jankowski0.0779%
- JHJennifer H. Allen0.0699%
- SDStephen Duane Oetgen0.0395%
- PEPatrick E. Allen0.02%
- ADArcline Double Eagle Master Fund-A LPNot reported
AI Activity Analysis
PremiumComing soon
Insider activity
Fromto
| Company | Insider / role | Action | ΔOwn | Avg price | Amount | ||
|---|---|---|---|---|---|---|---|
| ARXS | Ryan Anthony Jankowski | Open market purchase$125K | +9.5% | $28.00 | $125K | Apr 17, 2026 | Apr 20, 2026 |
| ARXS | Azad Sid Badakhsh | Open market purchase$1.01M | +9.8% | $28.00 | $1.01M | Apr 17, 2026 | Apr 20, 2026 |
| ARXS | Ross Bradley Sealfon | Open market purchase$350K | +1.2% | $28.00 | $350K | Apr 17, 2026 | Apr 20, 2026 |
| ARXS | Stephen Duane Oetgen | Open market purchase$700K | +466.7% | $28.00 | $700K | Apr 17, 2026 | Apr 20, 2026 |
| ARXS | Patrick E. Allen | Open market purchase$280K | +186.7% | $28.00 | $280K | Apr 17, 2026 | Apr 20, 2026 |
| ARXS | Kevin Scott Perhamus | Open market purchase$1.5M | +1.5% | $28.00 | $1.5M | Apr 17, 2026 | Apr 20, 2026 |
| ARXS | Jason Aaron Roth | Open market purchase$1.68M | +17.9% | $28.00 | $1.68M | Apr 17, 2026 | Apr 20, 2026 |